Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents

Hypomethylating agents (HMA) are the most commonly used therapeutic intervention in chronic myelomonocytic leukemia (CMML). Due to the lack of CMML-specific clinical trials, the impact of these agents in the natural history of CMML is not fully understood. We present the largest retrospective series...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Hematol
Main Authors: Alfonso, Ana, Montalban-Bravo, Guillermo, Takahashi, Koichi, Jabbour, Elias J., Kadia, Tapan, Ravandi, Farhad, Cortes, Jorge, Estrov, Zeev, Borthakur, Gautam, Pemmaraju, Naveen, Konopleva, Marina, Bueso-Ramos, Carlos, Pierce, Sherry, Kantarjian, Hagop, Garcia-Manero, Guillermo
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5553721/
https://ncbi.nlm.nih.gov/pubmed/28370097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24735
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados